Gene: CEP78
Official Full Name: centrosomal protein 78provided by HGNC
Gene Summary: This gene encodes a centrosomal protein that is both required for the regulation of centrosome-related events during the cell cycle, and required for ciliogenesis. The encoded protein has an N-terminal leucine-rich repeat (LRR) domain with six consecutive LRR repeats, and a C-terminal coiled-coil domain. It interacts with the N-terminal catalytic domain of polo-like kinase 4 (PLK4) and colocalizes with PLK4 to the distal end of the centriole. Naturally occurring mutations in this gene cause defects in primary cilia that result in retinal degeneration and sensorineural hearing loss which are associated with cone-rod degeneration disease as well as Usher syndrome. Low expression of this gene is associated with poor prognosis of colorectal cancer patients. [provided by RefSeq, Mar 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25171 | CEP78 Knockout cell line (HeLa) | Human | CEP78 | 1:3~1:6 | Negative | Online Inquiry |
KO25172 | CEP78 Knockout cell line (HCT 116) | Human | CEP78 | 1:2~1:4 | Negative | Online Inquiry |
KO25173 | CEP78 Knockout cell line (HEK293) | Human | CEP78 | 1:3~1:6 | Negative | Online Inquiry |
KO25174 | CEP78 Knockout cell line (A549) | Human | CEP78 | 1:3~1:4 | Negative | Online Inquiry |
CEP78 Gene Knockout Cell Lines are genetically modified models designed to facilitate the study of the CEP78 gene, which is implicated in various cellular processes including cilia formation, cell cycle regulation, and the response to cellular stress. By utilizing CRISPR/Cas9 technology, these cell lines exhibit a complete knockout of the CEP78 gene, thus providing researchers with a powerful tool to investigate the effects of gene loss on cellular function and pathway regulation.
The key mechanism of these cell lines lies in their ability to mimic pathological states that result from the absence of the CEP78 protein. By studying these knockout models, researchers can gain insight into the roles of CEP78 in critical intracellular mechanisms, potentially uncovering its contributions to diseases such as cancer and ciliopathies. The ability to observe alterations in cellular morphology, motility, and signaling pathways in a controlled environment significantly advances our understanding of gene functionality in both basic and applied research contexts.
The scientific importance of CEP78 Gene Knockout Cell Lines is underscored by their diverse applications. In clinical research, these models can aid in the identification of therapeutic targets and the development of innovative treatment strategies for conditions associated with CEP78 dysregulation. Furthermore, they are instrumental in drug screening assays, allowing for more accurate predictions of therapeutic efficacy and safety.
What sets CEP78 Gene Knockout Cell Lines apart from traditional cell models is their precision and reliability. Unlike previous gene disruption methods that may leave residual gene activity or produce off-target effects, the CRISPR/Cas9 approach employed in these cell lines ensures complete ablation of the target gene. This specificity offers researchers a clearer understanding of phenotypic changes attributable to CEP78 loss, facilitating more accurate experimental outcomes.
For researchers and clinicians, the value of CEP78 Gene Knockout Cell Lines is immense. They empower the exploration of fundamental biological questions and enhance translational research opportunities, ultimately bridging gaps between laboratory findings and clinical applications. By adopting these advanced cell lines into their studies, professionals can push the boundaries of genetic research and contribute to groundbreaking discoveries.
Our company is dedicated to providing high-quality biological products backed by extensive research and expertise in genetic engineering. With a commitment to supporting the scientific community, we offer innovative tools that meet the evolving needs of pioneering researchers and clinicians.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.